Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Correction

Published on 29 Sep 2023

Corrigendum: Cucurbitacin-B instigates intrinsic apoptosis and modulates Notch signaling in androgen-dependent prostate cancer LNCaP cells

in Pharmacology of Anti-Cancer Drugs

Ahmed Alafnan
Nasrin E. Khalifa
Talib Hussain
Mhdia Elhadi Osman

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1286507

1,674 views
1 citation

Review

Published on 28 Sep 2023

Lipid metabolism as a target for cancer drug resistance: progress and prospects

in Pharmacology of Anti-Cancer Drugs

Zi’an Wang
Yueqin Wang
Zeyun Li
Wenhua Xue
Shousen Hu
Xiangzhen Kong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1274335

7,939 views
42 citations

Systematic Review

Published on 28 Sep 2023

Methylene blue in anticancer photodynamic therapy: systematic review of preclinical studies

in Pharmacology of Anti-Cancer Drugs

Amir Taldaev
Roman Terekhov
Ilya Nikitin
Elizaveta Melnik
Vera Kuzina
Mikhail Klochko
Igor Reshetov
Artem Shiryaev
Victor Loschenov
Galina Ramenskaya

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1264961

149,230 views
25 citations

Review

Published on 28 Sep 2023

Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer

in Pharmacology of Anti-Cancer Drugs

Xuetong Shen
Chundi Gao
Huayao Li
Cun Liu
Longyun Wang
Ye Li
Ruijuan Liu
Changgang Sun
Jing Zhuang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1250893

7,709 views
10 citations

Original Research

Published on 28 Sep 2023

A new method to quantify the effect of co-medication on the efficacy of abiraterone in metastatic castration-resistant prostate cancer patients

in Pharmacology of Anti-Cancer Drugs

Bertalan Fekete
Lili Bársony
Krisztina Biró
Fruzsina Gyergyay
Lajos Géczi
Attila Patócs
Barna Budai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1220457

2,932 views

Review

Published on 28 Sep 2023

Photodynamic therapy and associated targeting methods for treatment of brain cancer

in Pharmacology of Anti-Cancer Drugs

Dorota Bartusik-Aebisher
Iga Serafin
Klaudia Dynarowicz
David Aebisher

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1250699

6,314 views
17 citations

Original Research

Published on 28 Sep 2023

Aqueous Nyctanthes arbortristis and doxorubicin conjugated gold nanoparticles synergistically induced mTOR-dependent autophagy-mediated ferritinophagy in paclitaxel-resistant breast cancer stem cells

in Pharmacology of Anti-Cancer Drugs

Prasanthi Chittineedi
Santhi Latha Pandrangi
Juan Alejandro Neira Mosquera
Sungey Naynee Sánchez Llaguno
Gooty Jaffer Mohiddin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1201319

3,825 views
9 citations

Editorial

Published on 27 Sep 2023

Editorial: Different cell death modes in cancer treatment

in Pharmacology of Anti-Cancer Drugs

Zhaoshi Bai
Jie Dou
Tareq Saleh
Jingwen Xu
Wufu Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1291585

1,350 views

Review

Published on 27 Sep 2023

Unlocking the role of non-coding RNAs in prostate cancer progression: exploring the interplay with the Wnt signaling pathway

in Pharmacology of Anti-Cancer Drugs

Tong Bu
Le Li
Jiyu Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1269233

3,007 views
8 citations

Original Research

Published on 26 Sep 2023

METTL3 promotes drug resistance to oxaliplatin in gastric cancer cells through DNA repair pathway

in Pharmacology of Anti-Cancer Drugs

Yi Wang
Zhongshi Hong
Jintian Song
Peilin Zhong
Liang Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1257410

3,202 views
8 citations

Review

Published on 25 Sep 2023

A literature review: mechanisms of antitumor pharmacological action of leonurine alkaloid

in Pharmacology of Anti-Cancer Drugs

Qiang Cao
Qi Wang
Xinyan Wu
Qi Zhang
Jinghan Huang
Yuquan Chen
Yanwei You
Yi Qiang
Xufeng Huang
Ronggao Qin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1272546

5,729 views
31 citations

Review

Published on 25 Sep 2023

The role of novel programmed cell death in head and neck squamous cell carcinoma: from mechanisms to potential therapies

in Pharmacology of Anti-Cancer Drugs

Yujie Xi
Ling Gao
Shaming Li
Kai Sun
Peishen Chen
Zhen Cai
Wenhao Ren
Keqian Zhi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1228985

4,238 views
4 citations

Review

Published on 25 Sep 2023

Updating the therapeutic role of ginsenosides in breast cancer: a bibliometrics study to an in-depth review

in Pharmacology of Anti-Cancer Drugs

Xianguang Deng
Juan Wang
Chenyi Lu
Yao Zhou
Lele Shen
Anqi Ge
Hongqiao Fan
Lifang Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1226629

6,160 views
5 citations

Original Research

Published on 25 Sep 2023

Metabolic reprogramming induced by DCA enhances cisplatin sensitivity through increasing mitochondrial oxidative stress in cholangiocarcinoma

in Pharmacology of Anti-Cancer Drugs

Hanjiao Qin
Ge Zheng
Qiao Li
Luyan Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1128312

3,773 views
13 citations

Original Research

Published on 21 Sep 2023

The construction of a prognostic model of cervical cancer based on four immune-related LncRNAs and an exploration of the correlations between the model and oxidative stress

in Pharmacology of Anti-Cancer Drugs

Xuefeng Lv
Yanyan Jia
Jinpeng Li
Shu Deng
Enwu Yuan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1234181

2,636 views
3 citations

Original Research

Published on 21 Sep 2023

Preclinical characterization of tunlametinib, a novel, potent, and selective MEK inhibitor

in Pharmacology of Anti-Cancer Drugs

Yahong Liu
Ying Cheng
Gongchao Huang
Xiangying Xia
Xingkai Wang
Hongqi Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1271268

5,264 views
10 citations